3 assets in Fucosidosis

Therapeutic assets addressing Fucosidosis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Busulfanum Fucosidosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Fucosidosis	Masonic Cancer Center, University of Minnesota	P2/3	B (62)
Cald Hr-D Fucosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)